A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus.

Saved in:
Bibliographic Details
Title: A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus.
Authors: Nakamura Y; Department of Endocrinology and Metabolism, Nagasaki University Hospital.; Department of Endocrinology and Metabolism, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Haraguchi A; Department of Endocrinology and Metabolism, Nagasaki University Hospital.; Department of Endocrinology and Metabolism, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Shigeno R; Department of Endocrinology and Metabolism, Nagasaki University Hospital.; Department of Endocrinology and Metabolism, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Ito A; Department of Endocrinology and Metabolism, Nagasaki University Hospital.; Department of Endocrinology and Metabolism, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Horie I; Department of Endocrinology and Metabolism, Nagasaki University Hospital.; Department of Endocrinology and Metabolism, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Kawakami A; Department of Endocrinology and Metabolism, Nagasaki University Hospital.; Department of Endocrinology and Metabolism, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Abiru N; Department of Endocrinology and Metabolism, Nagasaki University Hospital.; Department of Endocrinology and Metabolism, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Source: Medicine [Medicine (Baltimore)] 2021 Mar 12; Vol. 100 (10), pp. e25100.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1536-5964
DOI:10.1097/MD.0000000000025100